Do you want to skip to content? Skip to content
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本
Convatec Convatec False /oidc-signin/en-us/

Most visited pages

Reports, results and presentations
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本

15 October 2018

Reading, United Kingdom – Paul Moraviec, Chief Executive Officer of Convatec Group Plc (“Convatec” or “the Company”) has informed the Board of the Company that he wishes to retire. He will cease to be a Director with immediate effect.

The Board has asked Rick Anderson, currently a Non-Executive Director of Convatec and a former Group Chairman of Johnson & Johnson, to assume the position of Interim Chief Executive with immediate effect, until a suitable candidate is appointed to replace Mr Moraviec. Rick will be taking up his role on a full-time basis and will be based at the Group’s headquarters in Reading, United Kingdom. Mr Moraviec will continue to be available to the Company to ensure an orderly transition. The search for a new CEO will commence immediately and will be led by the Chairman, Sir Christopher Gent and Steve Holliday, the Deputy Chairman.

Sir Christopher Gent, Chairman of Convatec, said: “I would like to thank Paul for leading Convatec through an important phase of the Company’s development and the first period of being a public company. Paul leaves with the Board’s best wishes for his retirement. I am grateful to Rick for agreeing to take on executive responsibility as Interim Chief Executive Officer and I am sure the Company will be in very good hands until Paul’s replacement has been appointed.”

Paul Moraviec said: “We have made significant progress during my time as Chief Executive Officer and I am confident that Convatec now has the strong platform, infrastructure and leadership to enable the business to flourish. I would like to thank all my colleagues across Convatec for their hard work and dedication, they have taken Convatec to a leading position in the MedTech industry and I look forward to watching the Company’s future success.”

Rick Anderson will cease to be a member of the Audit and Risk Committee with immediate effect.

 

This announcement is made in accordance with LR 9.6.11R(1).

 

 

Enquiries

 
Media
                                                                                                                     

mediarelations@convatec.com

Bobby Leach, VP Group Corporate Affairs     

+44 (0)7770 842226

James Bradley / Alastair Elwen, Finsbury  

+44 (0)207 2513801

 

Press Release

See all

5/13/2022

Q1 Trading Update for the three months ended 31 March 2018

Read more

5/13/2022

Convatec announces changes within its U.S. Home Distribution Group

Read more

5/13/2022

Convatec announces 2018 Interim Results

Read more

5/13/2022

03 July 2018 - Board Changes

Read more

5/13/2022

Convatec Receives U.S. FDA 510(k) Clearance for Avelle™ Negative Pressure Wound Therapy System

Read more

5/13/2022

Trading update for the three months ended 30 September 2018 and change in FY 2018 guidance

Read more

5/13/2022

Retirement of Chief Executive Officer and appointment of Rick Anderson as Chief Executive Officer (Interim)

Read more

5/13/2022

US FDA 510(k) clearance for AQUACEL™ Ag Advantage

Read more

5/13/2022

Convatec Welcomes Wound Care Sector Deal

Read more